This topic contains a solution. Click here to go to the answer

Author Question: An NBA executive says that players who substitute as the sixth, seventh and eighth positions for the ... (Read 100 times)

bobbysung

  • Hero Member
  • *****
  • Posts: 519
An NBA executive says that players who substitute as the sixth, seventh and eighth positions for the games starting five players have a median playing time of 24 minutes. A random sample of 25 substitutes (6, 7 or 8) produces 20 non-zero differences in a Wilcoxon signed rank test and a W (R+) equal to 146 . The alternate hypothesis is m  24 minutes. Assume the population is symmetrically distributed. The computed test statistic in this situation equals:
 a. 146.
  b. 24.
  c. 25.
  d. 1.53.
  e. 41.

Question 2

The nonparametric counterpart to the one-sample t-test is the
 a. Wilcoxon signed rank test.
  b. Wilcoxon rank sum test.
  c. Kruskal-Wallis test.
  d. Friedman test for randomized block design.
  e. run test.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

vickyvicksss

  • Sr. Member
  • ****
  • Posts: 351
Answer to Question 1

D

Answer to Question 2

A





 

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

Did you know?

Eating food that has been cooked with poppy seeds may cause you to fail a drug screening test, because the seeds contain enough opiate alkaloids to register as a positive.

Did you know?

Illicit drug use costs the United States approximately $181 billion every year.

Did you know?

The shortest mature adult human of whom there is independent evidence was Gul Mohammed in India. In 1990, he was measured in New Delhi and stood 22.5 inches tall.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library